Investor

A&B

Last cheque observed Oct 2018. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series B

Cheques on record
0%of best year0cheques in 12 months, 2 on record
Since the last cheque2931days00hrs00min00sec
Median round$15MRounds led0 of 2Sole investor1 rounds
Pitch A&B

A&B highlights

  1. 01

    2 rounds on record

  2. 02

    Mostly Series B: 100% of its rounds

  3. 03

    Sole investor in 1 rounds, median $13M

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Cold pitches
Not stated

The record

Every round we can evidence, newest first2 appearances

  1. 2018

    2 rounds

  2. Oct
    ActicorSeries B · FR · Businesswire$18MWith 2 others
  3. Aug
    Blueberry TherapeuticsSeries B · GB · FinSMEs$13MSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Quick answers about A&B

What does A&B invest in?

A&B invests most often at Series B (100% of the rounds on record).

How active is A&B?

2 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2018.

What has A&B invested in recently?

Its most recent investments on record: Acticor (Series B, Oct 2018) and Blueberry Therapeutics (Series B, Aug 2018).

How big are A&B's cheques?

The median round it joins is $15M.

Is A&B investing now?

No investments in the last 12 months; the latest was in Oct 2018.

What kind of investor is A&B?

A&B is a growth equity firm.

Where does this information on A&B come from?

From 2 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it